Adjusting for Nonadherence or Stopping Treatments in Randomized Clinical Trials.

Amanda I Adler, Nicholas R Latimer

Journal: JAMA 2021;325(20):2110-2111

PMID: 34032845

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Diabetes Trials Unit, University of Oxford, Oxford, United Kingdom.; National Institute of Health and Clinical Excellence, London, United Kingdom.; School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom.

DOI: 10.1001/jama.2021.2433

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/34032845

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...
https://jamanetwork.com/journals/jama/fullarticle/...

MeSH Terms: Breast Neoplasms, Data Interpretation, Statistical, Diet, Fat-Restricted, Female, Humans, Intention to Treat Analysis, Patient Compliance, Randomized Controlled Trials as Topic